Platelets and cardiovascular risk

REFERENCES

• Kwak R, Back M, Bochaton-Piallat ML, Caligiuri G, Daemen MJ, Davies PF,Hoefer IE, Holvoet P, Jo H, Krams R, Lehoux S, Monaco C, Steffens S, Virmani R,Weber C, Wentzel JJ, Evans PC. Biomechanical factors in atherosclerosis: mechanisms and clinical implications. Eur Heart J 2014; 35: 3013–20.
   PubMed Web of Science ®Google Scholar
• He K, Liu K, Daviglus ML, Jenny NS, Mayer-Davis E, Jiang R, Steffen L, Siscovick D, Tsai M, Herrington D. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2009; 103: 1238–43.
   PubMed Web of Science ®Google Scholar
• Egert S, Stehle P. Impact of n-3 fatty acids on endothelial function: results from human interventions studies. Curr Opin Clin Nutr Metab Care 2011; 14: 121–31.
   PubMed Web of Science ®Google Scholar
• Robinson JG, Stone NJ. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol 2006; 98(4A): 39i–49i.
   PubMed Web of Science ®Google Scholar
• Massberg S, Brand K, Gruner S, Page S, Müller E, Müller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196: 887–96.
   PubMed Web of Science ®Google Scholar
• Schulz C, Schäfer A, Stolla M, Kerstan S, Lorenz M, von Brühl ML, Schiemann M, Bauersachs J, Gloe T, Busch DH, Gawaz M, Massberg S. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 2007; 116: 764–73.
   PubMed Web of Science ®Google Scholar
• Koyama H, Maeno T, Fukumoto S, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 2003; 108: 524–9.
   PubMed Web of Science ®Google Scholar
• Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 2661–6.
   PubMed Web of Science ®Google Scholar
• Santoso S, Sachs UJ, Kroll H, Linder M, Ruf A, Preissner KT, Chavakis T. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002; 196: 679–91.
   PubMed Web of Science ®Google Scholar
• Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C,Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61–7.
   PubMed Web of Science ®Google Scholar
• van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009; 85: 195–204.
   PubMed Web of Science ®Google Scholar
• von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100: 27–40.
   PubMed Web of Science ®Google Scholar
• Patzelt J, Langer HF. Platelets in angiogenesis. Curr Vasc Pharmacol 2012; 10: 570–7.
   PubMed Web of Science ®Google Scholar
• Siegel-Axel D, Daub K, Seizer P, Lindemann S, Gawaz M. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res 2008; 78: 8–17.
   PubMed Web of Science ®Google Scholar
• Stellos K, Sauter R, Fahrleitner M, Grimm J, Stakos D, Emschermann F, Panagiota V, Gnerlich S, Perk A, Schönberger T, Bigalke B, Langer HF, Gawaz M. Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo–brief report. Arterioscler Thromb Vasc Biol 2012; 32: 2017–20.
   PubMed Web of Science ®Google Scholar
• Ferroni P, Basili S, Santilli F, Davì G. Low-density lipoprotein-lowering medication and platelet function. Pathophysiol Haemost Thromb 2006; 35: 346–54.
   PubMedGoogle Scholar
• Harrison P, Keeling D. Clinical tests of platelet function. In: Michelson AD, ed. Platelets. 2nd ed. Elsevier, Inc./Academic Press, San Diego, CA, 2007; p. 445–74.
   Google Scholar
• Michelson AD. Platelet function testing in cardiovascular diseases. Circulation 2004; 110: e489–93.
   PubMed Web of Science ®Google Scholar
• Michelson AD, Frelinger AL III, Furman MI. Current options in platelet function testing. Am J Cardiol 2006; 98(10A): 4N–10N.
   PubMed Web of Science ®Google Scholar
• Breddin HK, Lippold R, Bittner M, Kirchmaier CM, Krzywanek HJ, Michaelis J. Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteers. Atherosclerosis 1999; 144: 211–9.
   PubMed Web of Science ®Google Scholar
• Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84: 613–7.
   PubMed Web of Science ®Google Scholar
• Meade TW, Cooper JA, Miller GJ. Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD). Thromb Haemost 1997; 78: 926–9.
   PubMed Web of Science ®Google Scholar
• Elwood PC, Renaud S, Beswick AD, O’Brien JR, Sweetnam PM. Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort. Heart 1998; 80: 578–82.
   PubMed Web of Science ®Google Scholar
• Sharp DS, Ben-Shlomo Y, Beswick AD, McCarron P, O’Brien JR, Renaud SR, Flower RJ. Platelet aggregation in whole blood is a paradoxical predictor of ischaemic stroke: Caerphilly Prospective Study revisited. Platelets 2005; 16: 320–8.
   PubMed Web of Science ®Google Scholar
• Kiliçli -Camur N, Demirtunç R, Konuralp C, Eskiser A, Başaran Y. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 2005; 11: CR387–CR392.
   PubMed Web of Science ®Google Scholar
• Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002; 117: 399–404.
   PubMed Web of Science ®Google Scholar
• Damodar S, Ganesh KV, Murthy S. Mean platelet volume does not predict risk of myocardial infarction or coronary artery disease in Indian patients. Platelets 2008; 19: 80–1.
   PubMed Web of Science ®Google Scholar
• Kristensen SD, Bath PM, Martin JF. Differences in bleeding time, aspirin sensitivity and adrenaline between acute myocardial infarction and unstable angina. Cardiovasc Res 1990; 24: 19–23.
   PubMed Web of Science ®Google Scholar
• Kishk YT, Trowbridge EA, Martin JF. Platelet volume subpopulations in acute myocardial infarction: an investigation of their homogeneity for smoking, infarct size and site. Clin Sci (Lond) 1985; 68: 419–25.
   PubMed Web of Science ®Google Scholar
• Yilmaz MB, Saricam E, Biyikoglu SF, Guray Y, Guray U, Sasmaz H, Korkmaz S. Mean platelet volume and exercise stress test. J Thromb Thrombolysis 2004; 17: 115–20.
   PubMed Web of Science ®Google Scholar
• Muscari A, De Pascalis S, Cenni A, Ludovico C, Castaldini N, Antonelli S, Bianchi G, Magalotti D, Zoli M. Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost 2008; 99: 1079–84.
   PubMed Web of Science ®Google Scholar
• Pizzulli L, Yang A, Martin JF, Lüderitz B. Changes in platelet size and count in unstable angina compared to stable angina or noncardiac chest pain. Eur Heart J 1998; 19: 80–4.
   PubMed Web of Science ®Google Scholar
• Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409–11.
   PubMed Web of Science ®Google Scholar
• Smyth DW, Martin JF, Michalis L, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest 1993; 23: 361–7.
   PubMed Web of Science ®Google Scholar
• Yang A, Pizzulli L, Lüderitz B. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 2006; 117: 371–7.
   PubMed Web of Science ®Google Scholar
• Butterworth RJ, Bath PM. The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets 1998; 9: 359–64.
   PubMed Web of Science ®Google Scholar
• Muscari A, Puddu GM, Cenni A, Silvestri MG, Giuzio R, Rosati M, Santoro N, Bianchi G, Magalotti D, Zoli M. Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes. Thromb Res 2009; 123: 587–91.
   PubMed Web of Science ®Google Scholar
• Bath P, Algert C, Chapman N. PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622–6.
   PubMed Web of Science ®Google Scholar
• Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004; 35: 1688–91.
   PubMed Web of Science ®Google Scholar
• Johnson-Tidey RR, McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol 1994; 144: 952–61.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103: 491–5.
   PubMed Web of Science ®Google Scholar
• Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003; 24: 2166–79.
   PubMed Web of Science ®Google Scholar
• Reiner AP, Carlson CS, Thyagarajan B, Rieder MJ, Polak JF, Siscovick DS, Nickerson DA, Jacobs DR Jr, Gross MD. Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 2008; 28: 1549–55.
   PubMed Web of Science ®Google Scholar
• Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A, Haskard D. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 2001; 358: 971–6.
   PubMed Web of Science ®Google Scholar
• Ravnskov U. The fallacies of the lipid hypothesis. Scand Cardiovasc J 2008; 42: 236–9.
   PubMed Web of Science ®Google Scholar
• Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987; 257: 2176–80.
   PubMed Web of Science ®Google Scholar
• Ford ES, De Stefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Am J Epidemiol 1991; 133: 1220–30.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frölich J, Böger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001; 358: 2113–7.
   PubMed Web of Science ®Google Scholar
• Behar S, Graff E, Reicher-Reiss H, Boyko V, Benderly M, Shotan A, Brunner D. Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study Group. Eur Heart J 1997; 18: 52–9.
   PubMed Web of Science ®Google Scholar
• Ravnskov U. High cholesterol may protect against infections and atherosclerosis. QJM 2003; 96: 927–34.
   PubMed Web of Science ®Google Scholar